Log in to search using one of your social media accounts:

 

Invicta Medical raises $21m for sleep apnea device

Sleep apnea device developer Invicta Medical has raised approximately $21 million in a new round of equity financing, according to an SEC filing posted this week. The Palo Alto, Calif.-based company, founded in 2013, has not yet revealed the technology behind its development but claims that its solution to treating obstructive sleep apnea is non-invasive, customizable to meet patient needs and affordable, according to its website. The company has not yet officially stated how it plans to spend funds raised in the round. The round was joined by 6 anonymous investors, with the first sale in the round dated on December 20, 2017, according to the SEC filing. The post Invicta Medical raises $21m for sleep apnea device appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Respiratory invictamedical Source Type: news

Related Links:

The incidence of new-onset atrial fibrillation (NOAF) is increasing both in the Asian populations and Western countries. Several demographic and clinical risk factors were independently associated with NOAF, including ageing, male sex, obesity, obstructive sleep apnea syndrome, hypertension, coronary artery disease, renal dysfunction and heart failure. However, some differences in the incidence of NOAF, the prevalence of some risk factors and lifestyle or environmental conditions may exist between Asian and Western countries.
Source: International Journal of Cardiology - Category: Cardiology Authors: Source Type: research
Ramakant DixitLung India 2018 35(3):191-192
Source: Lung India - Category: Respiratory Medicine Authors: Source Type: research
Association between obstructive sleep apnea and optic neuropathy: a Taiwanese population-based cohort study, Published online: 26 April 2018; doi:10.1038/s41433-018-0088-1Association between obstructive sleep apnea and optic neuropathy: a Taiwanese population-based cohort study
Source: Eye - Category: Opthalmology Authors: Source Type: research
Inspire Medical Systems is seeking to raise about $75 million through an initial public offering. The company said the IPO was for 5 million shares of its common stock and the price is expected to be between $14 and $16 per share. Inspire has been approved to list its common stock on the New York Stock Exchange under the ticker symbol “INSP.” The Minneapolis-based company has developed a neurostimulation device that provides treatment for moderate-to-severe obstructive sleep apnea (OSA). The technology is a closed-loop solution that uses an algorithm to continuously monitor a patient’s breathing patterns ...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Implants Source Type: news
In the United States, nearly 30 million adults are affected by sleep apnea. This condition occurs when the upper airway repeatedly collapses during sleep, resulting in snoring and daytime sleepiness.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Inspire Medical Systems this week set the range for a proposed initial public offering that would fetch $75 million at the midpoint. Maple Grove, Minn.-based Inspire, which spun out from Medtronic (NYSE:MDT) in 2007, makes devices for treating obstructive sleep apnea. The company said it plans to issue 5 million shares at $14 to $16 apiece, setting its market capitalization at roughly $305 million. Inspire, which posted net losses of -$17.5 million on sales of $28.6 million last year, plans to list on the New York Stock Exchange under the INSP symbol. The flotation is slated to price next week. The company d...
Source: Mass Device - Category: Medical Devices Authors: Tags: Funding Roundup Initial Public Offering (IPO) Respiratory Wall Street Beat Inspire Medical Systems Inc. Medtronic Source Type: news
In the United States, nearly 30 million adults are affected by sleep apnea. This condition occurs when the upper airway repeatedly collapses during sleep, resulting in snoring and daytime sleepiness.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Journal of Cellular Physiology, EarlyView.
Source: Journal of Cellular Physiology - Category: Cytology Authors: Source Type: research
ConclusionsThus, to consider the relationship between OSA and obesity, it is important to know the reciprocal relationships among OSA, obesity, and short sleep duration.
Source: Current Oral Health Reports - Category: Dentistry Source Type: research
CONCLUSION: Our study suggests that gender-specific consideration needs to be incorporated into the application of STOP-Bang in a clinically referred patient population with a higher risk of OSA. Alternative scoring systems may improve predictive performance of STOP-Bang. PMID: 29691799 [PubMed - as supplied by publisher]
Source: Sleep and Breathing - Category: Sleep Medicine Authors: Tags: Sleep Breath Source Type: research
More News: Obstructive Sleep Apnea | Respiratory Medicine | Sleep Apnea | Sleep Disorders | Sleep Medicine | Websites